Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-01-03

Clinical Trial Update: SGLT2 Inhibitors on Clinical Outcomes and Left Ventricular Remodeling in Type 2 Diabetic Patients with Acute Myocardial Infarction, a Prospective, Multi-center Registry Study

View source ↗

Summary

A prospective, multi-center registry study evaluating the effects of SGLT2 inhibitors on clinical outcomes and left ventricular remodeling in patients with type…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • SGLT2 inhibitor (class) (SGLT2 inhibitor)

Snippet

Sponsor: Kiyuk Chang | Conditions: Myocardial Infarction, Diabetes Mellitus, Type 2 | Status: RECRUITING